Send feedback

MRTFA p.Ala863Val

c.2588C>T · rs200338788 · VCV1682938

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.1276 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00782%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense0.1276likely benign
REVEL0.091moderately benign-leaning
SaProtLLR -7.47tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 9.9GERP 1.2, phastCons 1
Regional constrainto/e 1.06unconstrained · MANE · 13 kb · p 0.043 · regional, not allelic
Overall
CADD23.4PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM A763V vs ClinVar A863V) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00782% European (non-Finnish) · 87/1,112,342 alleles
Filtering AF 0.0065% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00599%
Overall 0.0118% 174/1,477,452 alleles · very rare exomes 162/1,325,164 · genomes 12/152,288 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.291% 344
Remaining individualsnot grpmax-eligible 0.0284% 3,523
European (non-Finnish)grpmax 0.00782% 12,786
Admixed American 0.00738% 13,555
African / African-American 0.00282% 35,510

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MRTFA
Protein
p.Ala863Val
Coding
c.2588C>T
MANE Select
NM_020831
dbSNP
rs200338788
Type
single nucleotide variant
Location
chr22:40411898 (GRCh38)
Gene constraint
LOEUF 0.389 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 56.59 · 2 PDB
Residue 763 UniProt numbering
the 'disordered' region; a UniProt-annotated variant site (in imd66; probable loss-of-function; patient's dendritic cells are morphologically distinct from control dendritic cells and show reduced spreading on fibronectin-coated coverslips, a marked reduction in total f-actin staining and a complete absence of podosomes, a similar phenotype to that of thp1 cells in which mrtfa was silenced)
Full MRTFA gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mrtfa-p-ala863val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown